DFG remains skeptical of the cloning of human cellsJanuary 23, 2008Priority is given to reprogramming research According to a paper published in the journal Stem Cells, an American group has succeeded in inserting cell nuclei from human skin cells into human enucleated oocytes and to stimulate these new cells to undergo cell division in the laboratory. This may constitute the first step on the way towards cloning human cells. Many issues relating to the method employed remain unclear at present. The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) already expressed its scepticism regarding the process of "therapeutic cloning" or "research cloning" when it released a statement on the issue of stem cell research in the autumn of 2006. Both for scientific reasons, and because this method calls for a large number of eggs from young donors, the DFG has given clear priority to research into reprogramming methods. Developments since late 2006 have confirmed the DFG's stance. Research done by American and Japanese groups, for example, has shown that it is possible to convert human skin cells back into cells similar to stem cells by treating them with reprogramming factors.
The DFG is also very critical of recent findings in the field of "research cloning in the human system". Experiments of this kind are prohibited in Germany, as is importing cloned cell lines. The DFG has no intention of changing its current position. Rather, the DFG continues to support research into the reprogramming of adult and embryonic stem cells. Deutsche Forschungsgemeinschaft | |||||||||||||||||||||
|
Related Stem Cells News Articles Small protein may have big role in making more bone and less fat A small protein may have a big role in helping you make more bone and less fat, researchers say. Researchers link early stem cell mutation to autism In a breakthrough scientific study published today in the Proceedings of the National Academy of Sciences, scientists at the Burnham Institute for Medical Research have shown that neural stem cell development may be linked to Autism. How to build a plant Walking through a tropical or temperate forest immediately impresses us with the myriad forms and soaring structures of the plant world, but our knowledge of how plants are actually built, cell by cell, is still incomplete. Nerve cells derived from stem cells and transplanted into mice may lead to improved brain treatments Scientists at the Burnham Institute for Medical Research have, for the first time, genetically programmed embryonic stem (ES) cells to become nerve cells when transplanted into the brain, according to a study published today in The Journal of Neuroscience. New source of heart stem cells discovered Researchers at Children's Hospital Boston are continuing to document the heart's earliest origins. Now, they have pinpointed a new, previously unrecognized group of stem cells that give rise to cardiomyocytes, or heart muscle cells. Penn researchers find key developmental pathway activates lung stem cells Researchers from the University of Pennsylvania School of Medicine found that the activation of a molecular pathway important in stem cell and developmental biology leads to an increase in lung stem cells. Harnessing this knowledge could help develop therapies for lung-tissue repair after injury or disease. Ability to track stem cells in tumors could advance cancer treatments Using noninvasive molecular imaging technology, a method has been developed to track the location and activity of mesenchymal stem cells (MSCs) in the tumors of living organisms. Wealth of genomic hotspots discovered in embryonic stem cells In a paper published in Cell on June 13, 2008, Singapore scientists at the Genome Institute of Singapore (GIS) and the National University of Singapore (NUS) unveil an atlas that showing the location of "genomic hotspots" of essential protein "switches" (transcription factors) that are critical for maintaining the embryonic stem (ES) cell state. 'HiCy' drug regimen reverses ms symptoms in selected patients A short-term, very-high dose regimen of the immune-suppressing drug cyclophosphamide seems to slow progression of multiple sclerosis (MS) in most of a small group of patients studied and may even restore neurological function lost to the disease, Johns Hopkins researchers report. Human stem cells show promise against fatal children's diseases Scientists have used human stem cells to dramatically improve the condition of mice with a neurological condition similar to a set of diseases in children that are invariably fatal, according to an article in the June issue of the journal Cell Stem Cell. More Stem Cells News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||